23 min listen
How to Avoid Getting "Tyked" Off When Learning About New JAK Inhibitors In Psoriasis
How to Avoid Getting "Tyked" Off When Learning About New JAK Inhibitors In Psoriasis
ratings:
Length:
12 minutes
Released:
Oct 28, 2021
Format:
Podcast episode
Description
Live from The Wynn Hotel and Casino in Las Vegas, NV, episode 13 of Derms and Conditions, has our host James Q. Del Rosso, DO speaking with Bruce Strober, MD in person at the 2021 Fall Clinical Dermatology Conference. First Dr. Strober discusses older biologic agents in psoriasis and how JAK inhibitors offer improved efficacy while not compromising on safety.
Dr. Strober further discusses in depth how certain JAK inhibitors interact with TYK2 and what he thinks are the most important points regarding this pathway in psoriasis pathophysiology. Finally, Dr. Strober discusses in detail why allosteric binding offers improved specificity in JAK inhibition.
Dr. Strober further discusses in depth how certain JAK inhibitors interact with TYK2 and what he thinks are the most important points regarding this pathway in psoriasis pathophysiology. Finally, Dr. Strober discusses in detail why allosteric binding offers improved specificity in JAK inhibition.
Released:
Oct 28, 2021
Format:
Podcast episode
Titles in the series (80)
Where are we now with CBD and other questions facing dermatology? Perspectives from Adam Friedman, MD by Derms and Conditions